Back to Search Start Over

Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

Authors :
Carmine Carpenito
F. Brad Johnson
John Scholler
Sonny Ang
Jesse M. Platt
Carl H. June
Avery D. Posey
Shannon E. McGettigan
Shinichiro Motohashi
Sonia Guedan
Laurence J.N. Cooper
Maria C. Basil
Michael C. Milone
Chrystal M. Paulos
Matthew J. Frigault
Omkar U. Kawalekar
Jihyun Lee
Michael Kalos
Yangbing Zhao
Source :
Cancer Immunology Research. 3:356-367
Publication Year :
2015
Publisher :
American Association for Cancer Research (AACR), 2015.

Abstract

This study compared second-generation chimeric antigen receptors (CAR) encoding signaling domains composed of CD28, ICOS, and 4-1BB (TNFRSF9). Here, we report that certain CARs endow T cells with the ability to undergo long-term autonomous proliferation. Transduction of primary human T cells with lentiviral vectors encoding some of the CARs resulted in sustained proliferation for up to 3 months following a single stimulation through the T-cell receptor (TCR). Sustained numeric expansion was independent of cognate antigen and did not require the addition of exogenous cytokines or feeder cells after a single stimulation of the TCR and CD28. Results from gene array and functional assays linked sustained cytokine secretion and expression of T-bet (TBX21), EOMES, and GATA-3 to the effect. Sustained expression of the endogenous IL2 locus has not been reported in primary T cells. Sustained proliferation was dependent on CAR structure and high expression, the latter of which was necessary but not sufficient. The mechanism involves constitutive signaling through NF-κB, AKT, ERK, and NFAT. The propagated CAR T cells retained a diverse TCR repertoire, and cellular transformation was not observed. The CARs with a constitutive growth phenotype displayed inferior antitumor effects and engraftment in vivo. Therefore, the design of CARs that have a nonconstitutive growth phenotype may be a strategy to improve efficacy and engraftment of CAR T cells. The identification of CARs that confer constitutive or nonconstitutive growth patterns may explain observations that CAR T cells have differential survival patterns in clinical trials. Cancer Immunol Res; 3(4); 356–67. ©2015 AACR.

Details

ISSN :
23266074 and 23266066
Volume :
3
Database :
OpenAIRE
Journal :
Cancer Immunology Research
Accession number :
edsair.doi.dedup.....f16bfc3e4d3a93d981b4c4989621a48a